The patient journey: A report of skin cancer care across Europe

British Journal of Dermatology

Volumn 167, Issue SUPPL. 2, 2012, Pages 43-52

  Trakatelli, M ^a   Siskou, S ^a   Proby, C ^b   Tiplica, G S ^c   Hinrichs, B ^d   Altsitsiadis, E ^d,k   Kitsou, A ^a   Ferrandiz, L ^e   Aquilina, S ^f   Apap, C ^f   Ulrich, M ^d   Fiorentini, C ^g   Magnoni, C ^g   De Vries, E ^h   Flohil, S C ^h   Kalokasidis, K ^a   Moreno Ramirez, D ^e   Ruiz De Casas, A ^e   Majewski, S ⁱ   Ranki, A ^j   Pitkanen S ^j   Saksela, O ^j   Ioannides, D ^a   Sotiriadis, D ^a   Stockfleth, E ^d   more..

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^f Sir Paul Boffa Hospital   (Malta)

^g UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^h ERASMUS MEDICAL CENTER   (Netherlands)

ⁱ MEDICAL UNIVERSITY OF WARSAW   (Poland)

^j HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^k UNIVERSITY OF LEUVEN   (Belgium)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER; DICLOFENAC; FLUOROURACIL; IMIQUIMOD;

ACTINIC KERATOSIS; ARTICLE; BASAL CELL CARCINOMA; CANCER PATIENT; CONSULTATION; COST OF ILLNESS; DERMATOLOGIST; EUROPE; EUROPEAN UNION; FINLAND; GERMANY; GREECE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE DISPARITY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH INSURANCE; HUMAN; ITALY; MALTA; MELANOMA; MORBIDITY; NETHERLANDS; PATIENT CARE; PHOTODYNAMIC THERAPY; POLAND; PRIORITY JOURNAL; REIMBURSEMENT; ROMANIA; SKIN CANCER; SPAIN; SQUAMOUS CELL CARCINOMA; UNITED KINGDOM;

ANTINEOPLASTIC AGENTS; COSTS AND COST ANALYSIS; DERMATOLOGIC AGENTS; DERMATOLOGY; DRUG COSTS; EUROPEAN UNION; GENERAL PRACTITIONERS; HEALTHCARE DISPARITIES; HUMANS; PRACTICE GUIDELINES AS TOPIC; REFERRAL AND CONSULTATION; SKIN NEOPLASMS;

EID: 84865039768     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2012.11086.x     Document Type: Article

References (27)

1. de Vries E, Bray F, Coebergh JWW, et al. Changing epidemiology of malignant cutaneous melanoma in Europe 1969-1997: rising trends in incidence and mortality, but recent stabilisations in Western Europe and decreases in Scandinavia. Int J Cancer 2003; 107: 119-26.
2. Trakatelli M, Ulrich C, del Marmol V, et al. Epidemiology of nonmelanoma skin cancer (NMSC) in Europe: accurate and comparable data are needed for effective public health monitoring and interventions. Br J Dermatol 2007; 156 (Suppl. 3): 1-7.
3. Lucas R, McMichael T, Smith W, et al. Solar Ultraviolet Radiation. Global Burden of Disease from Solar Ultraviolet Radiation. Environmental Burden of Disease Series No. 13. Geneva: World Health Organization, 2006.
4. Housman TS, Feldman SR, Williford PM, et al. Skin cancer is among the most costly of all cancers to treat for the Medicare population. J Am Acad Dermatol 2003; 48: 425-9.
5. Boyle P, Dore JF, Autier P, et al. Cancer of the skin: a forgotten problem in Europe. Ann Oncol 2004; 15: 5-6.
6. Reyes-Ortiz CA, Goodwin JS, Freeman JL,. The effect of socioeconomic factors on incidence, stage at diagnosis and survival of cutaneous melanoma. Med Sci Monit 2005; 11: RA163-72.
7. Mudigonda T, Pearce DJ, Yentzer BA, et al. The economic impact of non-melanoma skin cancer: a review. J Natl Compr Canc Netw 2010; 8: 888-96.
8. Cancer Research UK. Skin Cancer-Survival Statistics. 2009. Available at: http://info.cancerresearchuk.org/cancerstats/types/skin/survival/ (last accessed 12 April 2012).
9. ISD Scotland. Cancer Statistics. Skin Cancer. 2010. Available at: http://www.isdscotland.org/Health-Topics/Cancer/Cancer-Statistics/ (last accessed 13 April 2012).
10. de Vries E, Boniol M, Dore JF, et al. and EUROCARE Working Group. Lower incidence rates but thicker melanomas in Eastern Europe before 1992: a comparison with Western Europe. Eur J Cancer 2004; 40: 1045-52.
11. Mackenbach JP,. Health Inequalities: Europe in Profile. An Independent, Expert Report Commissioned by the UK Presidency of the EU. 2006. Available at: http://ec.europa.eu/health/ph-determinants/socio-economics/documents/ ev-060302-rd06-en.pdf (last accessed 12 April 2012).
12. Jakubowski E, Busse R,. Health Care Systems in the EU. A Comparative Study. 1998. Available at: http://www.europarl.europa.eu/workingpapers/saco/pdf/ 101-en.pdf (last accessed 12 April 2012).
13. de Vries E, Trakatelli M, Kalabalikis D, et al. Known and potential new risk factors for skin cancer in European populations: a multicentre case-control study. Br J Dermatol 2012; 167 (Suppl. 2): 1-13.
14. de Vries E, Micallef R, Brewster DH, et al. Population-based estimates of the occurrence of multiple vs first primary basal cell carcinomas in 4 European regions. Arch Dermatol 2012; 148: 347-54.
15. Karim-Kos HE, de Vries E, Soerjomataram I, et al. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 2008; 44: 1345-89.
16. Ferrandiz L, Ruiz-de-Casas A, Trakatelli M, et al. Assessing physicians' preferences on skin cancer treatment in Europe. Br J Dermatol 2012; 167 (Suppl. 2): 29-35.
17. Working group set up by the Finnish Medical Society Duodecim and the Chirurgi Plastici Fenniae. Melanoma. Current Care Summary. 2012. Available at: http://www.kaypahoito.fi/web/kh/suositukset/naytaartikkeli/tunnus/ccs00017 (last accessed 12 April 2012).
18. Hauschild A, Breuninger H, Kaufman R, et al. Short German guidelines: basal cell carcinoma. J Dtsch Dermatol Ges 2008; 6 (Suppl. 1): S2-4.
19. Breuninger H, Bootz F, Hauschild A, et al. Short German guidelines: squamous cell carcinoma. J Dtsch Dermatol Ges 2008; 6 (Suppl. 1): S5-8.
20. Garbe C, Schadendorf D, Stolz W, et al. Short German guidelines: malignant melanoma. J Dtsch Dermatol Ges 2008; 6 (Suppl. 1): S9-14.
21. Bichakjian CK, Halpern AC, Johnson TM, et al. Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol 2011; 65: 1032-47.
22. Balch C, Gershenwald J, Soong SJ,. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009; 27: 6199-206.
23. Marsden JR, Newton-Bishop JA, Burrows L, et al. Revised U.K. guidelines for the management of cutaneous melanoma 2010. Br J Dermatol 2010; 163: 238-56.
24. Ministry of Health (Romania). Guidelines for Dermato-venereologic Diseases. Available at: http://www.ms.ro/?pag=181&pg=2 (last accessed 12 April 2012).
25. de la Cruz Merino L, Moreno-Ramirez D, Ferrandiz Pulido L, et al. Guia de Diagnõstico y Tratamiento del Melanoma. Seville: Hospital Virgen Macarena, 2009.
26. Telfer NR, Colver GB, Morton CA,. Guidelines for the management of basal cell carcinoma. Br J Dermatol 2008; 159: 35-48.
27. Motley RJ, Preston PW, Lawrence CM,. Multi-professional Guidelines for the Management of the Patient with Primary Cutaneous Squamous Cell Carcinoma. 2009. Available at: http://www.bad.org.uk/Portals/-Bad/Guidelines/ Clinical%20Guidelines/SCC%20Guidelines%20Final%20Aug%2009.pdf (last accessed 13 April 2012).